Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Highlighting spin selectivity properties of chiral electrode surfaces from redox potential modulation of an achiral probe under an applied magnetic field.

Benincori T, Arnaboldi S, Magni M, Grecchi S, Cirilli R, Fontanesi C, Mussini PR.

Chem Sci. 2019 Jan 4;10(9):2750-2757. doi: 10.1039/c8sc04126a. eCollection 2019 Mar 7.

2.

Towards efficient sustainable full-copper dye-sensitized solar cells.

Dragonetti C, Magni M, Colombo A, Fagnani F, Roberto D, Melchiorre F, Biagini P, Fantacci S.

Dalton Trans. 2019 Jul 2;48(26):9703-9711. doi: 10.1039/c9dt00790c.

PMID:
30969290
3.

Formation of by-products during chemical interesterification of lipids. Detection and characterization of dialkyl ketones by non-aqueous reversed-phase liquid chromatography-high resolution mass spectrometry and gas chromatography-mass spectrometry.

Santoro V, Baiocchi C, Dal Bello F, Gastaldi D, Aigotti R, Zorzi M, Pellegrino A, Forte E, Romaniello F, Magni M, Fontana M, Somenzi M, Medana C.

J Chromatogr A. 2018 Dec 21;1581-1582:63-70. doi: 10.1016/j.chroma.2018.11.001. Epub 2018 Nov 3.

PMID:
30446267
4.

TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage.

Magni M, Buscemi G, Maita L, Peng L, Chan SY, Montecucco A, Delia D, Zannini L.

Cell Death Differ. 2019 May;26(5):918-931. doi: 10.1038/s41418-018-0168-6. Epub 2018 Jul 26.

PMID:
30050056
5.

Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiology.

Magni M, Buscemi G, Zannini L.

Mutat Res. 2018 Apr - Jun;776:1-9. doi: 10.1016/j.mrrev.2018.03.004. Epub 2018 Mar 19. Review.

PMID:
29807573
6.

Characterization and Determination of Interesterification Markers (Triacylglycerol Regioisomers) in Confectionery Oils by Liquid Chromatography-Mass Spectrometry.

Santoro V, Bello FD, Aigotti R, Gastaldi D, Romaniello F, Forte E, Magni M, Baiocchi C, Medana C.

Foods. 2018 Feb 16;7(2). pii: E23. doi: 10.3390/foods7020023.

7.

Intriguing C-HCu interactions in bis-(phenanthroline)Cu(i) redox mediators for dye-sensitized solar cells.

Colombo A, Ossola R, Magni M, Roberto D, Jacquemin D, Castellano C, Demartin F, Dragonetti C.

Dalton Trans. 2018 Jan 23;47(4):1018-1022. doi: 10.1039/c7dt04045h.

8.

Coupling of Zinc Porphyrin Dyes and Copper Electrolytes: A Springboard for Novel Sustainable Dye-Sensitized Solar Cells.

Colombo A, Di Carlo G, Dragonetti C, Magni M, Orbelli Biroli A, Pizzotti M, Roberto D, Tessore F, Benazzi E, Bignozzi CA, Casarin L, Caramori S.

Inorg Chem. 2017 Nov 20;56(22):14189-14197. doi: 10.1021/acs.inorgchem.7b02323. Epub 2017 Nov 1.

PMID:
29091412
9.

Emergency Preparedness and Management at the University of L'aquila (Central Italy) and the Role of Students' Associations in the April 6th 2009 Earthquake.

Magni M, Fraboni R, Marincioni F.

PLoS Curr. 2017 Jan 12;9. pii: ecurrents.dis.5df8f1902f10be8920342035c77c14e3. doi: 10.1371/currents.dis.5df8f1902f10be8920342035c77c14e3.

10.

Survivors' Solidarity and Attachment in the Immediate Aftermath of the Typhoon Haiyan (Philippines).

Bartolucci A, Magni M.

PLoS Curr. 2017 Jan 9;9. pii: ecurrents.dis.2fbd11bd4c97d74fd07882a6d50eabf2. doi: 10.1371/currents.dis.2fbd11bd4c97d74fd07882a6d50eabf2.

11.

A novel crosstalk between CCAR2 and AKT pathway in the regulation of cancer cell proliferation.

Restelli M, Magni M, Ruscica V, Pinciroli P, De Cecco L, Buscemi G, Delia D, Zannini L.

Cell Death Dis. 2016 Nov 3;7(11):e2453. doi: 10.1038/cddis.2016.359.

12.

Long-term safety of growth hormone replacement therapy after childhood medulloblastoma and PNET: it is time to set aside old concerns.

Indini A, Schiavello E, Biassoni V, Bergamaschi L, Magni MC, Puma N, Chiaravalli S, Pallotti F, Seregni E, Diletto B, Pecori E, Gandola L, Poggi G, Massimino M.

J Neurooncol. 2017 Jan;131(2):349-357. doi: 10.1007/s11060-016-2306-7. Epub 2016 Oct 21.

PMID:
27770281
13.

Tetracoordinated Bis-phenanthroline Copper-Complex Couple as Efficient Redox Mediators for Dye Solar Cells.

Magni M, Giannuzzi R, Colombo A, Cipolla MP, Dragonetti C, Caramori S, Carli S, Grisorio R, Suranna GP, Bignozzi CA, Roberto D, Manca M.

Inorg Chem. 2016 Jun 6;55(11):5245-53. doi: 10.1021/acs.inorgchem.6b00204. Epub 2016 May 23.

14.

Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.

Ruella M, Filippi AR, Bruna R, Di Russo A, Magni M, Caracciolo D, Passera R, Matteucci P, Di Nicola M, Corradini P, Parvis G, Gini G, Olivieri A, Ladetto M, Ricardi U, Tarella C, Devizzi L.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):783-91. doi: 10.1016/j.ijrobp.2015.12.019. Epub 2015 Dec 17.

PMID:
26972651
15.

CCAR2/DBC1 is required for Chk2-dependent KAP1 phosphorylation and repair of DNA damage.

Magni M, Ruscica V, Restelli M, Fontanella E, Buscemi G, Zannini L.

Oncotarget. 2015 Jul 10;6(19):17817-31.

16.

New thiocyanate-free ruthenium(II) sensitizers with different pyrid-2-yl tetrazolate ligands for dye-sensitized solar cells.

Colombo A, Dragonetti C, Magni M, Meroni D, Ugo R, Marotta G, Grazia Lobello M, Salvatori P, De Angelis F.

Dalton Trans. 2015 Jul 14;44(26):11788-96. doi: 10.1039/c5dt01216c. Epub 2015 Jun 8.

17.

Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation.

Raggi D, Mariani L, Giannatempo P, Lo Vullo S, Giardiello D, Nicolai N, Piva L, Biasoni D, Catanzaro M, Torelli T, Stagni S, Maffezzini M, Calareso G, Magni M, Di Nicola M, Verzoni E, Grassi P, Procopio G, De Braud F, Pizzocaro G, Salvioni R, Necchi A.

Urol Oncol. 2015 Jul;33(7):332.e19-24. doi: 10.1016/j.urolonc.2015.04.008. Epub 2015 May 16.

PMID:
25985712
18.

Inherently chiral electrodes: the tool for chiral voltammetry.

Arnaboldi S, Benincori T, Cirilli R, Kutner W, Magni M, Mussini PR, Noworyta K, Sannicolò F.

Chem Sci. 2015 Mar 1;6(3):1706-1711. doi: 10.1039/c4sc03713h. Epub 2015 Jan 13.

19.

Exchange of single amino acids at different positions of a recombinant protein affects metabolic burden in Escherichia coli.

Rahmen N, Fulton A, Ihling N, Magni M, Jaeger KE, Büchs J.

Microb Cell Fact. 2015 Jan 23;14:10. doi: 10.1186/s12934-015-0191-y.

20.

Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis.

Magni M, Ruscica V, Buscemi G, Kim JE, Nachimuthu BT, Fontanella E, Delia D, Zannini L.

Nucleic Acids Res. 2014 Dec 1;42(21):13150-60. doi: 10.1093/nar/gku1065. Epub 2014 Oct 31.

21.

High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study.

Necchi A, Mariani L, Di Nicola M, Lo Vullo S, Nicolai N, Giannatempo P, Raggi D, Farè E, Magni M, Piva L, Matteucci P, Catanzaro M, Biasoni D, Torelli T, Stagni S, Bengala C, Barone C, Schiavetto I, Siena S, Carlo-Stella C, Pizzocaro G, Salvioni R, Gianni AM.

Ann Oncol. 2015 Jan;26(1):167-72. doi: 10.1093/annonc/mdu485. Epub 2014 Oct 24.

PMID:
25344361
22.

Efficient copper mediators based on bulky asymmetric phenanthrolines for DSSCs.

Colombo A, Dragonetti C, Magni M, Roberto D, Demartin F, Caramori S, Bignozzi CA.

ACS Appl Mater Interfaces. 2014 Aug 27;6(16):13945-55. doi: 10.1021/am503306f. Epub 2014 Aug 14.

PMID:
25078128
23.

Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapy.

Mirabile A, Celio L, Magni M, Bonizzoni E, Gianni AM, Di Nicola M.

Future Oncol. 2014 Dec;10(16):2569-78. doi: 10.2217/fon.14.132.

PMID:
24947121
24.

Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.

Zappasodi R, Cavanè A, Iorio MV, Tortoreto M, Guarnotta C, Ruggiero G, Piovan C, Magni M, Zaffaroni N, Tagliabue E, Croce CM, Zunino F, Gianni AM, Di Nicola M.

Int J Cancer. 2014 Nov 1;135(9):2034-45. doi: 10.1002/ijc.28852. Epub 2014 Mar 26. Erratum in: Int J Cancer. 2017 Nov 1;141(9):E6.

25.

Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis.

Magni M, Di Nicola M, Patti C, Scimè R, Mulè A, Rambaldi A, Intermesoli T, Viero P, Tarella C, Gueli A, Bergui L, Trentin L, Barzan A, Benedetti F, Ambrosetti A, Di Raimondo F, Chiarenza A, Parvis G, Billio A, Attolico I, Olivieri A, Montanari M, Carlo-Stella C, Matteucci P, Devizzi L, Guidetti A, Viviani S, Valagussa P, Gianni AM.

Bone Marrow Transplant. 2014 Apr;49(4):485-91. doi: 10.1038/bmt.2013.214. Epub 2014 Jan 20.

PMID:
24442244
26.

Psychological care of caregivers, nurses and physicians: a study of a new approach.

Abeni MS, Magni M, Conte M, Mangiacavalli S, Pochintesta L, Vicenzi G, Ferretti VV, Pompa A, Cocito F, Klersy C, Corso A.

Cancer Med. 2014 Feb;3(1):101-10. doi: 10.1002/cam4.163. Epub 2014 Jan 4.

27.

Predictors of CD34+ cell mobilization and collection in adult men with germ cell tumors: implications for the salvage treatment strategy.

Necchi A, Miceli R, Pedrazzoli P, Giannatempo P, Secondino S, Di Nicola M, Farè E, Raggi D, Magni M, Matteucci P, Longoni P, Milanesi M, Paternò E, Ravagnani F, Arienti F, Nicolai N, Salvioni R, Carlo-Stella C, Gianni AM.

Clin Genitourin Cancer. 2014 Jun;12(3):196-202.e1. doi: 10.1016/j.clgc.2013.11.021. Epub 2013 Nov 13.

PMID:
24361054
28.

Thiocyanate-free ruthenium(II) sensitizer with a pyrid-2-yltetrazolate ligand for dye-sensitized solar cells.

Dragonetti C, Colombo A, Magni M, Mussini P, Nisic F, Roberto D, Ugo R, Valore A, Valsecchi A, Salvatori P, Lobello MG, De Angelis F.

Inorg Chem. 2013 Oct 7;52(19):10723-5. doi: 10.1021/ic401794g. Epub 2013 Sep 11.

PMID:
24024624
29.

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.

Devizzi L, Guidetti A, Seregni E, Passera R, Maccauro M, Magni M, Testi A, Di Nicola M, Tarella C, Matteucci P, Viviani S, Ruella M, Carlo-Stella C, Chiesa C, Cox MC, Bombardieri E, Gianni AM.

J Clin Oncol. 2013 Aug 10;31(23):2974-6. doi: 10.1200/JCO.2013.50.2922. Epub 2013 Jul 15. No abstract available.

30.

Successful second autologous engraftment after long duration storage of hematopoietic stem cells.

Longoni P, Milanesi M, Di Nicola M, Devizzi L, Carrabba M, Arienti F, Ravagnani F, Tarella C, Montefusco V, Gianni A, Corradini P, Magni M.

Bone Marrow Transplant. 2013 Nov;48(11):1480-1. doi: 10.1038/bmt.2013.81. Epub 2013 May 27. No abstract available.

PMID:
23708707
31.

Mortality in the l'aquila (central Italy) earthquake of 6 april 2009.

Alexander D, Magni M.

PLoS Curr. 2013 Jan 7;5:e50585b8e6efd1. doi: 10.1371/50585b8e6efd1.

32.

Detection of minimal residual disease in hematopoietic progenitor cell harvests: lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma.

Magni M, Di Nicola M, Carlo-Stella C, Matteucci P, Devizzi L, Guidetti A, Ravagnani F, Gianni AM.

Am J Blood Res. 2012;2(2):105-12. Epub 2012 Apr 15.

33.

Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.

Zappasodi R, Bongarzone I, Ghedini GC, Castagnoli L, Cabras AD, Messina A, Tortoreto M, Tripodo C, Magni M, Carlo-Stella C, Gianni AM, Pupa SM, Di Nicola M.

Blood. 2011 Oct 20;118(16):4421-30. doi: 10.1182/blood-2011-06-364570. Epub 2011 Aug 22.

34.

Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma.

Tarella C, Passera R, Magni M, Benedetti F, Rossi A, Gueli A, Patti C, Parvis G, Ciceri F, Gallamini A, Cortelazzo S, Zoli V, Corradini P, Carobbio A, Mulé A, Bosa M, Barbui A, Di Nicola M, Sorio M, Caracciolo D, Gianni AM, Rambaldi A.

J Clin Oncol. 2011 Mar 1;29(7):814-24. doi: 10.1200/JCO.2010.28.9777. Epub 2010 Dec 28.

PMID:
21189387
35.

Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.

Zappasodi R, Pupa SM, Ghedini GC, Bongarzone I, Magni M, Cabras AD, Colombo MP, Carlo-Stella C, Gianni AM, Di Nicola M.

Cancer Res. 2010 Nov 15;70(22):9062-72. doi: 10.1158/0008-5472.CAN-10-1825. Epub 2010 Sep 30.

36.

Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience.

Viviani S, Di Nicola M, Bonfante V, Di Stasi A, Carlo-Stella C, Matteucci P, Magni M, Devizzi L, Valagussa P, Gianni AM.

Leuk Lymphoma. 2010 Jul;51(7):1251-9. doi: 10.3109/10428194.2010.486090.

PMID:
20528244
37.

Intranuclear sphingomyelin is associated with transcriptionally active chromatin and plays a role in nuclear integrity.

Scassellati C, Albi E, Cmarko D, Tiberi C, Cmarkova J, Bouchet-Marquis C, Verschure PJ, Driel Rv, Magni MV, Fakan S.

Biol Cell. 2010 Apr 1;102(6):361-75. doi: 10.1042/BC20090139.

PMID:
20095965
38.

Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.

Lavazza C, Carlo-Stella C, Giacomini A, Cleris L, Righi M, Sia D, Di Nicola M, Magni M, Longoni P, Milanesi M, Francolini M, Gloghini A, Carbone A, Formelli F, Gianni AM.

Blood. 2010 Mar 18;115(11):2231-40. doi: 10.1182/blood-2009-08-239632. Epub 2010 Jan 14.

39.

Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma: long-term follow-up.

Magni M, Di Nicola M, Carlo-Stella C, Devizzi L, Guidetti A, Matteucci P, Gianni AM.

Bone Marrow Transplant. 2010 Jun;45(6):1119-20. doi: 10.1038/bmt.2009.294. Epub 2009 Oct 12. No abstract available.

PMID:
19820728
40.

Effect of 1alpha,25-dihydroxyvitamin D3 in embryonic hippocampal cells.

Marini F, Bartoccini E, Cascianelli G, Voccoli V, Baviglia MG, Magni MV, Garcia-Gil M, Albi E.

Hippocampus. 2010 Jun;20(6):696-705. doi: 10.1002/hipo.20670.

PMID:
19603526
41.

Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.

Rossi D, Spina V, Cerri M, Rasi S, Deambrogi C, De Paoli L, Laurenti L, Maffei R, Forconi F, Bertoni F, Zucca E, Agostinelli C, Cabras A, Lucioni M, Martini M, Magni M, Deaglio S, Ladetto M, Nomdedeu JF, Besson C, Ramponi A, Canzonieri V, Paulli M, Marasca R, Larocca LM, Carbone A, Pileri SA, Gattei V, Gaidano G.

Clin Cancer Res. 2009 Jul 1;15(13):4415-22. doi: 10.1158/1078-0432.CCR-08-3266. Epub 2009 Jun 9.

42.

Radioimmunotherapy and secondary leukemia: a case report.

Magni M, Di Nicola M, Testi A, Cabras A, Devizzi L, Guidetti A, Matteucci P, Viviani S, Bonfante V, Carniti C, Ricca I, Carbone A, Carlo-Stella C, Gianni AM.

Leuk Res. 2010 Jan;34(1):e1-4. doi: 10.1016/j.leukres.2009.04.028. Epub 2009 May 15.

PMID:
19446876
43.

High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.

Magni M, Di Nicola M, Carlo-Stella C, Matteucci P, Devizzi L, Tarella C, Benedetti F, Martelli M, Patti C, Parvis G, Rambaldi A, Barbui T, Gianni AM.

Bone Marrow Transplant. 2009 Mar;43(6):509-11. doi: 10.1038/bmt.2008.349. Epub 2008 Oct 27. No abstract available.

PMID:
18955979
44.

Lipid microdomains in cell nucleus.

Cascianelli G, Villani M, Tosti M, Marini F, Bartoccini E, Magni MV, Albi E.

Mol Biol Cell. 2008 Dec;19(12):5289-95. doi: 10.1091/mbc.E08-05-0517. Epub 2008 Oct 15.

45.

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.

Devizzi L, Guidetti A, Tarella C, Magni M, Matteucci P, Seregni E, Chiesa C, Bombardieri E, Di Nicola M, Carlo-Stella C, Gianni AM.

J Clin Oncol. 2008 Nov 10;26(32):5175-82. doi: 10.1200/JCO.2008.16.8294. Epub 2008 Oct 14.

PMID:
18854569
46.

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.

Di Nicola M, Zappasodi R, Carlo-Stella C, Mortarini R, Pupa SM, Magni M, Devizzi L, Matteucci P, Baldassari P, Ravagnani F, Cabras A, Anichini A, Gianni AM.

Blood. 2009 Jan 1;113(1):18-27. doi: 10.1182/blood-2008-06-165654. Epub 2008 Sep 22.

47.

Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.

Tarella C, Zanni M, Magni M, Benedetti F, Patti C, Barbui T, Pileri A, Boccadoro M, Ciceri F, Gallamini A, Cortelazzo S, Majolino I, Mirto S, Corradini P, Passera R, Pizzolo G, Gianni AM, Rambaldi A.

J Clin Oncol. 2008 Jul 1;26(19):3166-75. doi: 10.1200/JCO.2007.14.4204. Epub 2008 May 19.

PMID:
18490650
48.

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).

Tarella C, Zanni M, Di Nicola M, Patti C, Calvi R, Pescarollo A, Zoli V, Fornari A, Novero D, Cabras A, Stella M, Comino A, Remotti D, Ponzoni M, Caracciolo D, Ladetto M, Magni M, Devizzi L, Rosato R, Boccadoro M, Bregni M, Corradini P, Gallamini A, Majolino I, Mirto S, Gianni AM; Gruppo Italiano Terapie Innovative nei Linfomi.

Leukemia. 2007 Aug;21(8):1802-11. Epub 2007 Jun 7.

PMID:
17554382
49.

Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress Reagent.

Lavazza C, Carlo-Stella C, Di Nicola M, Longoni P, Milanesi M, Magni M, Gianni AM.

Exp Hematol. 2007 Jun;35(6):888-97.

PMID:
17533043
50.

IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3.

Carlo-Stella C, Guidetti A, Di Nicola M, Lavazza C, Cleris L, Sia D, Longoni P, Milanesi M, Magni M, Nagy Z, Corradini P, Carbone A, Formelli F, Gianni AM.

Cancer Res. 2007 Apr 1;67(7):3269-75.

Supplemental Content

Support Center